X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2059) 2059
Book Review (212) 212
Publication (76) 76
Conference Proceeding (4) 4
Magazine Article (3) 3
Newsletter (3) 3
Book Chapter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1893) 1893
humans (1800) 1800
female (1280) 1280
male (1250) 1250
adult (1009) 1009
hematology (944) 944
middle aged (892) 892
busulfan - adverse effects (867) 867
transplantation (823) 823
busulfan (819) 819
oncology (727) 727
adolescent (655) 655
busulfan - administration & dosage (646) 646
immunology (549) 549
busulfan - therapeutic use (489) 489
child (485) 485
bone-marrow-transplantation (477) 477
aged (425) 425
cyclophosphamide (420) 420
transplantation conditioning - methods (410) 410
transplantation, homologous (377) 377
treatment outcome (375) 375
child, preschool (364) 364
hematopoietic stem cell transplantation - adverse effects (348) 348
hematopoietic stem cells (339) 339
stem cells (338) 338
retrospective studies (322) 322
chemotherapy (306) 306
hematopoietic stem cell transplantation (296) 296
antineoplastic combined chemotherapy protocols - therapeutic use (276) 276
transplantation conditioning - adverse effects (269) 269
cyclophosphamide - administration & dosage (268) 268
total-body irradiation (263) 263
cyclophosphamide - adverse effects (260) 260
stem-cell transplantation (257) 257
bone marrow transplantation (253) 253
leukemia (250) 250
infant (239) 239
risk factors (235) 235
vidarabine - analogs & derivatives (232) 232
children (228) 228
hematopoietic stem cell transplantation - methods (221) 221
bone marrow transplantation - adverse effects (215) 215
combined modality therapy (212) 212
survival analysis (211) 211
abridged index medicus (209) 209
disease-free survival (207) 207
versus-host-disease (204) 204
animals (202) 202
young adult (202) 202
graft vs host disease - etiology (200) 200
transplantation conditioning (200) 200
cancer (191) 191
bone-marrow transplantation (190) 190
antineoplastic combined chemotherapy protocols - adverse effects (186) 186
therapy (182) 182
stem cell transplantation (180) 180
transplantation, autologous (179) 179
follow-up studies (177) 177
graft vs host disease - prevention & control (176) 176
toxicity (171) 171
pharmacokinetics (166) 166
recurrence (163) 163
leukemia, myeloid - drug therapy (161) 161
care and treatment (160) 160
survival rate (160) 160
health aspects (159) 159
cyclophosphamide - therapeutic use (158) 158
fludarabine (158) 158
hematology, oncology and palliative medicine (152) 152
time factors (151) 151
acute myeloid-leukemia (146) 146
vidarabine - administration & dosage (143) 143
antineoplastic agents - adverse effects (141) 141
bone marrow (136) 136
busulfan - pharmacokinetics (135) 135
dose-response relationship, drug (129) 129
whole-body irradiation (128) 128
dosage and administration (127) 127
mortality (126) 126
analysis (125) 125
leukemia, myeloid, acute - therapy (125) 125
research (125) 125
immunosuppressive agents - therapeutic use (120) 120
pediatrics (119) 119
prospective studies (118) 118
hematologic neoplasms - therapy (116) 116
melphalan - administration & dosage (115) 115
immunosuppressive agents - adverse effects (114) 114
mice (113) 113
incidence (112) 112
high-dose busulfan (111) 111
antineoplastic combined chemotherapy protocols - administration & dosage (110) 110
prognosis (108) 108
survival (108) 108
acute disease (106) 106
busulfan - analogs & derivatives (101) 101
melphalan (100) 100
remission induction (97) 97
graft survival (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1872) 1872
German (51) 51
French (36) 36
Spanish (22) 22
Japanese (20) 20
Chinese (17) 17
Polish (13) 13
Russian (13) 13
Italian (7) 7
Dutch (5) 5
Hungarian (3) 3
Danish (2) 2
Portuguese (2) 2
Czech (1) 1
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 11, pp. 1502 - 1508
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 701 - 709
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2011, Volume 17, Issue 7, pp. 1072 - 1078
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell transplantation (aHCT). Recent National Institutes of... 
Hematology, Oncology and Palliative Medicine | Chronic graft-versus-host disease | Allogeneic hematopoietic cell transplantation | Bronchiolitis obliterans syndrome | RISK-FACTORS | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | BONE-MARROW TRANSPLANTATION | LUNG-DISEASE | NONINFECTIOUS PULMONARY COMPLICATIONS | HEMATOLOGY | AIR-FLOW OBSTRUCTION | Spirometry | Graft vs Host Disease - epidemiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Postoperative Complications - etiology | Prevalence | Immunoglobulin G - blood | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Busulfan - administration & dosage | Incidence | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Retrospective Studies | Postoperative Complications - drug therapy | Transplantation Conditioning - methods | Transplantation, Homologous - adverse effects | Busulfan - adverse effects | Bronchiolitis Obliterans - etiology | Risk Factors | Bronchiolitis Obliterans - immunology | European Continental Ancestry Group | Postoperative Complications - epidemiology | Bronchiolitis Obliterans - epidemiology | Postoperative Complications - diagnosis | Bronchiolitis Obliterans - diagnosis | Graft vs Host Disease - drug therapy | Adolescent | Bone Marrow Transplantation - adverse effects | Aged | Bronchiolitis Obliterans - drug therapy | Chronic Disease | Early Diagnosis | Index Medicus | Bronchiolitis Obliterans Syndrome | Allogeneic Hematopoietic Cell Transplantation | Chronic Graft-Versus-Host Disease
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 9, pp. 1627 - 1635
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 11, pp. 2665 - 2672
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 11/2015, Volume 50, Issue 11, pp. 1438 - 1444
We evaluated prospectively the incidence and risk factors of the metabolic syndrome (MS) and its components in 170 adult patients (mean age at evaluation: 24.8... 
TOTAL-BODY IRRADIATION | LONG-TERM SURVIVORS | ENDOTHELIAL DYSFUNCTION | BONE-MARROW-TRANSPLANTATION | IMPAIRED GLUCOSE-TOLERANCE | IMMUNOLOGY | TRANSPLANTATION | DIABETES-MELLITUS | ONCOLOGY | INSULIN-RESISTANCE | ACUTE LYMPHOBLASTIC-LEUKEMIA | CARDIOVASCULAR-DISEASE | HEMATOLOGY | GROWTH-HORMONE DEFICIENCY | Myeloablative Agonists - therapeutic use | Metabolic Syndrome - etiology | Prospective Studies | Myeloablative Agonists - adverse effects | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Whole-Body Irradiation - adverse effects | Young Adult | Metabolic Syndrome - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Lipids - blood | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Body Mass Index | Blood Glucose - analysis | Busulfan - therapeutic use | Risk Factors | Proportional Hazards Models | Survivors | Combined Modality Therapy | Antineoplastic Agents, Alkylating - therapeutic use | Adrenal Cortex Hormones - adverse effects | Waist Circumference | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Cholesterol, HDL - blood | Antineoplastic Agents, Alkylating - adverse effects | Adrenal Cortex Hormones - administration & dosage | Complications and side effects | Stem cell research | Care and treatment | Development and progression | Transplantation | Metabolic syndrome X | Acute lymphocytic leukemia | Hematopoietic stem cells | Index Medicus | Life Sciences
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2011, Volume 118, Issue 15, pp. 4258 - 4264
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 8, pp. 1211 - 1218
Although allogeneic hematopoietic cell transplantation (HCT) has proven curative potential for myelodysplastic syndrome, relapse after HCT remains a problem.... 
Hematology, Oncology and Palliative Medicine | Myelodysplastic syndrome (MDS) | Reduced-intensity conditioning | Induction chemotherapy | Hypomethylation | Azacitidine | TOTAL-BODY IRRADIATION | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | UNRELATED DONORS | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | ADVANCED MYELODYSPLASTIC SYNDROME | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | TARGETED BUSULFAN | Recurrence | Azacitidine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Induction Chemotherapy | Male | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Retrospective Studies | Transplantation Conditioning - methods | Child | Myelodysplastic Syndromes - surgery | Myelodysplastic Syndromes - drug therapy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Azacitidine - therapeutic use | Antimitotic agents | Care and treatment | Chemotherapy | Leukemia | Patient outcomes | Oncology, Experimental | Transplantation | Research | Antineoplastic agents | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 148 - 156
Purpose We have demonstrated that toxicities are acceptable with total marrow irradiation (TMI) at 16 Gy without chemotherapy or TMI at 12 Gy and the reduced... 
Radiology | Hematology, Oncology and Palliative Medicine | TOTAL-BODY IRRADIATION | MULTIPLE-MYELOMA | ETOPOSIDE | ONCOLOGY | CYCLOPHOSPHAMIDE | BONE-MARROW | RANDOMIZED-TRIAL | EXPERIENCE | GUIDED TOTAL-MARROW | HELICAL TOMOTHERAPY | REGIMENS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Recurrence | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Liver - radiation effects | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Bone Marrow - radiation effects | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Whole-Body Irradiation - adverse effects | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Liver - drug effects | Adult | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Leukemia, Myeloid, Acute - therapy | Radiotherapy Dosage | Busulfan - adverse effects | Etoposide - adverse effects | Induction Chemotherapy - methods | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy - adverse effects | Stomatitis - etiology | Leukemia, Myeloid, Acute - mortality | Whole-Body Irradiation - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Combined Modality Therapy - methods | Bone marrow | Chemotherapy | Transplantation | Nuclear radiation | Hematopoietic stem cells | Cancer | Index Medicus | IRRADIATION | PATIENTS | HEALTH HAZARDS | MYLERAN | FAILURES | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | BONE MARROW | ENDOXAN | RADIATION DOSES | TOXICITY | LEUKEMIA | total marrow irradiation | tomotherapy | total body irradiation | bone marrow transplantation | acute leukemia
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2017, Volume 35, Issue 11, pp. 1154 - 1161
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2014, Volume 49, Issue 7, pp. 913 - 920
Journal Article